Association of CYP1B1 polymorphisms and breast cancer risk.
暂无分享,去创建一个
G. Colditz | D. Hunter | S. Hankinson | Lisa Li | I. De Vivo | D. Hunter
[1] L. Kolonel,et al. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[2] N. Roodi,et al. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. , 2000, Cancer research.
[3] J. Liehr,et al. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. , 2000, Cancer research.
[4] T. Shimada,et al. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. , 1999, Carcinogenesis.
[5] W. Willett,et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. , 1999, Cancer research.
[6] N. Roodi,et al. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. , 1998, Cancer research.
[7] J. Manson,et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. , 1998, Journal of the National Cancer Institute.
[8] J A McKay,et al. Tumor-specific expression of cytochrome P450 CYP1B1. , 1997, Cancer research.
[9] T. Sutter,et al. Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells , 1997, The Journal of Steroid Biochemistry and Molecular Biology.
[10] N. Walker,et al. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Liehr,et al. 4-Hydroxylation of estrogens as marker of human mammary tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] W. F. Greenlee,et al. Expression of cytochrome P450 CYP1B1 in breast cancer , 1995, FEBS letters.
[13] C. Jefcoate,et al. The effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: Evidence for induction of a novel 17β-estradiol 4-hydroxylase , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[14] J. Liehr,et al. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. , 1994, Carcinogenesis.
[15] G. Vollmer,et al. Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[16] G. Vollmer,et al. Catecholestrogens are MCF-7 cell estrogen receptor agonists , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[17] E. Schuetz,et al. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. , 1992, Archives of biochemistry and biophysics.
[18] Li Jj,et al. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. , 1987 .